$50,000 of CACI INTERNATIONAL INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Cross-government work to further organizational missions"
You can find more data on corporate lobbying on Quiver Quantitative.
CACI Congressional Stock Trading
Members of Congress have traded $CACI stock 9 times in the past 6 months. Of those trades, 2 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CACI stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $50,000 on 01/31 and 1 sale worth up to $50,000 on 04/08.
- REPRESENTATIVE KELLY MORRISON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 03/20.
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 3 times. They made 1 purchase worth up to $15,000 on 02/27 and 2 sales worth up to $30,000 on 02/22, 02/18.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 02/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CACI Insider Trading Activity
CACI insiders have traded $CACI stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CACI stock by insiders over the last 6 months:
- WILLIAM L JEWS sold 1,036 shares for an estimated $494,607
- DEBORA A PLUNKETT sold 309 shares for an estimated $112,358
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CACI Hedge Fund Activity
We have seen 279 institutional investors add shares of CACI stock to their portfolio, and 310 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 757,963 shares (+2128.9%) to their portfolio in Q1 2025, for an estimated $278,111,783
- MORGAN STANLEY added 402,361 shares (+26.8%) to their portfolio in Q1 2025, for an estimated $147,634,298
- BOSTON PARTNERS added 327,008 shares (+14514.3%) to their portfolio in Q1 2025, for an estimated $119,985,775
- RIVER ROAD ASSET MANAGEMENT, LLC added 266,556 shares (+1254.6%) to their portfolio in Q1 2025, for an estimated $97,804,727
- FIL LTD added 241,158 shares (+2114.1%) to their portfolio in Q1 2025, for an estimated $88,485,693
- SELECT EQUITY GROUP, L.P. removed 217,476 shares (-85.3%) from their portfolio in Q1 2025, for an estimated $79,796,293
- CITADEL ADVISORS LLC removed 215,910 shares (-91.7%) from their portfolio in Q1 2025, for an estimated $79,221,697
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CACI Analyst Ratings
Wall Street analysts have issued reports on $CACI in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 07/07/2025
- Stifel issued a "Buy" rating on 06/24/2025
- Barclays issued a "Overweight" rating on 04/29/2025
- Wells Fargo issued a "Overweight" rating on 04/28/2025
- Truist Securities issued a "Buy" rating on 04/25/2025
- Jefferies issued a "Buy" rating on 03/25/2025
To track analyst ratings and price targets for CACI, check out Quiver Quantitative's $CACI forecast page.
CACI Price Targets
Multiple analysts have issued price targets for $CACI recently. We have seen 6 analysts offer price targets for $CACI in the last 6 months, with a median target of $511.5.
Here are some recent targets:
- Jonathan Siegmann from Stifel set a target price of $576.0 on 06/24/2025
- David Strauss from Barclays set a target price of $510.0 on 04/29/2025
- Matthew Akers from Wells Fargo set a target price of $513.0 on 04/28/2025
- Tobey Sommer from Truist Securities set a target price of $525.0 on 04/25/2025
- Sheila Kahyaoglu from Jefferies set a target price of $455.0 on 03/25/2025
- Brian Gesuale from Raymond James set a target price of $490.0 on 01/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
